| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
9,860,000 |
| Market
Cap: |
4.34(M) |
| Last
Volume: |
343,990 |
Avg
Vol: |
272,835 |
| 52
Week Range: |
$0.258 - $0.8194 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,283,690 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,979,170 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
3,747,968 |
3,747,968 |
| Total Sell Value |
$0 |
$0 |
$4,610,000 |
$4,610,000 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Choong Choon Hau |
10% Owner |
– – • |
2024-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
54,132 |
3,802,100 |
|
- |
|
| Greenberg Eric Howard |
Director |
– • – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
66,250 |
|
- |
|
| Natan David |
Director |
– • – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
66,250 |
|
- |
|
| Mcmurdo Matthew Charles |
Director |
– • – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
66,250 |
|
- |
|
| Ben-Tzvi Avraham |
Director |
– • – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
66,250 |
|
- |
|
| Beebe Katherine |
President and COO |
• • – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
66,250 |
|
- |
|
| Shen Seow Gim |
10% Owner |
– – • |
2023-09-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,836,266 |
|
-5% |
|
| Lazar David E. |
Chief Executive Officer |
• • – |
2023-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Ben-Tzvi Avraham |
Director |
– • – |
2023-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Greenberg Eric Howard |
Director |
– • – |
2023-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Chasey Peter Louis |
Director |
– • – |
2023-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Beebe Katherine |
President and COO |
• • – |
2023-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Mcmurdo Matthew Charles |
Director |
– • – |
2023-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Natan David |
Director |
– • – |
2023-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Choong Choon Hau |
10% Owner |
– – • |
2023-06-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,747,968 |
|
-38% |
|
| Activist Investing Llc |
Member of 10% owner group |
– – – |
2023-06-21 |
4 |
S |
$1.23 |
$441,651 |
I/I |
(359,066) |
0 |
|
44% |
|
| Activist Investing Llc |
Member of 10% owner group |
– – – |
2023-06-21 |
4 |
S |
$1.23 |
$4,168,349 |
D/D |
(3,388,902) |
0 |
|
44% |
|
| Activist Investing Llc |
Member of 10% owner group |
– – – |
2023-01-25 |
4 |
B |
$1.00 |
$20,066 |
D/D |
20,000 |
3,388,902 |
2.44 |
-23% |
|
| Activist Investing Llc |
Member of 10% owner group |
– – – |
2023-01-24 |
4 |
B |
$0.97 |
$36,221 |
D/D |
37,500 |
3,368,902 |
2.44 |
-21% |
|
| Activist Investing Llc |
Member of 10% owner group |
– – – |
2022-07-07 |
4 |
B |
$0.99 |
$739,010 |
D/D |
744,294 |
3,331,402 |
2.44 |
-16% |
|
| Activist Investing Llc |
|
– – – |
2022-07-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
43,145 |
|
4% |
|
| Activist Investing Llc |
|
– – – |
2022-07-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,421,133 |
|
4% |
|
| Activist Investing Llc |
Member of 10% owner group |
– – – |
2022-07-06 |
4 |
B |
$0.89 |
$281,991 |
I/I |
315,921 |
359,066 |
0.01 |
4% |
|
| Activist Investing Llc |
Member of 10% owner group |
– – – |
2022-07-06 |
4 |
B |
$0.77 |
$901,882 |
D/D |
1,165,975 |
2,587,108 |
2.44 |
4% |
|
| Mcnab James R |
Director |
– • – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
I/I |
51,021 |
51,021 |
|
- |
|
54 Records found
|
|
Page 1 of 3 |
|
|
